Search Results 31-40 of 930 for Kronik Lumbalji

  1. Publications - Ande M. Rumilla, M.D. - Mayo Clinic

    RNA-Seq Reveals Differences in Expressed Tumor Mutation Burden in Colorectal and Endometrial Cancers with and without Defective DNA-Mismatch Repair. J Mol Diagn ...

  2. Gastroenterology and Hepatology - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. Increase competitive edge - KPJ Damansara Specialist Hospital - Mayo Clinic

    Mayo Clinic Care Network helped KPJ Damansara Specialist Hospital design a Nurse Navigator program that transforms cancer care coordination and patient ...

  5. Drugs and Supplements that Start with K - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “K” to learn about drug side effects, proper use and ...

  6. Gastroenterology and Hepatology - Clinical trials

    This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...

  7. A Study To Evaluate Outpatient Blinatumomab In Subjects With Minimal Residual Disease (MRD) Of B-precursor Acute Lymphoblastic Leukemia (ALL) - Mayo Clinic

    The purpose of this study is to determine the safety and feasibility of complete outpatient blinatumomab administration for subjects with minimal residual ...

  8. Gastroenterology and Hepatology - Clinical trials

    This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...

  9. Anthony L. Mikula, M.D. - Mayo Clinic Faculty Profiles

    Anthony L. Mikula, M.D., is a fellowship-trained spine neurosurgeon whose research centers on spinal tumors and complex spinal deformity at Mayo Clinic.

  10. A Study To Evaluate Acalabrutinib With Or Without Obinutuzumab To Treat Early-Stage Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma Patients - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...